跳至主要内容
临床试验/EUCTR2009-014830-10-AT
EUCTR2009-014830-10-AT进行中(未招募)不适用

Glucose Control in Pre-Diabetic Renal Transplant Patients: Efficacy and Safety of Vildagliptin and Pioglitazone - GCPD

Medizinische Universität Wien, Univ.Klinik Innere Medizin III, Abt.für Nephrologie u.Dialyse0 个研究点开始时间: 2009年10月14日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Time since renal transplantation > 6 months
  • Stable graft function
  • Routine OGTT has been performed, and pre-diabetes has been diagnosed by pathological OGTT (2h, 75 g glucose, glucose level between 140 and 200 mg/dl)
  • Informed consent of the patient
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patients with type 1 or type 2 diabetes
  • Patients with NODAT (2h glucose level at OGTT >200 mg/dl)
  • allergy against vildagliptin or pioglitazone
  • GFR < 30 ml/min
  • hepatic impairment

研究者

发起方
Medizinische Universität Wien, Univ.Klinik Innere Medizin III, Abt.für Nephrologie u.Dialyse

相似试验